Editorial [Hot topic: Adipocytokines in Nonalcoholic Fatty Liver Disease: Key Players Regulating Steatosis, Inflammation and Fibrosis (Executive Editor: Herbert Tilg)]

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|17|1893-1895

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.17, 2010-06, pp. : 1893-1895

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Hot Topic: Update on Treatment Strategies in Patients with Non-alcoholic Fatty Liver Disease)

By  

Current Pharmaceutical Design, Vol. 19, Iss. 29, 2013-09 ,pp. : 5167-5168

Bentham Science Publishers

Access to resources Recommend Favorite

Retinol-Binding Protein 4 and New Adipocytokines in Nonalcoholic Fatty Liver Disease

By  

Current Pharmaceutical Design, Vol. 16, Iss. 17, 2010-06 ,pp. : 1921-1928

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: New Developments in Pharmaceutical Treatments for Cystic Fibrosis (Executive Guest Editor: Hartmut Grasemann)]

By  

Current Pharmaceutical Design, Vol. 18, Iss. 5, 2012-02 ,pp. : 613-613

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: New Insights and Strategies in Treating Inflammation-Related Diseases (Executive Editor: Tz-Chong Chou)]

By  

Current Pharmaceutical Design, Vol. 12, Iss. 27, 2006-09 ,pp. : 3495-3495

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Redox Status in the Pathophysiology of Inflammation and Therapeutic Targets (Executive Editor: Mena Soory)]

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 9, Iss. 4, 2009-08 ,pp. : 375-375

Bentham Science Publishers

Access to resources Recommend Favorite